Zepbound Overdose or Double Dose: What to Do Now

At a glance

  • Suspected extra or double dose / contact Poison Help now
  • Poison Help / 1-800-222-1222 in the United States
  • Severe emergency symptoms / call 911 or the local emergency number
  • Specific antidote / none identified in the FDA label
  • Label approach / supportive treatment based on signs and symptoms
  • Observation / may be necessary because tirzepatide's half-life is about five days
  • Do not / induce vomiting, skip or add medication to compensate, or rely on a generic online dose calculator

Take the Action Before Solving the Math

The current FDA label is direct: in an overdosage, contact the Poison Help Line at 1-800-222-1222 or a medical toxicologist for management recommendations [1]. Poison Control provides the same immediate route by phone or through webPOISONCONTROL [2].

Do not wait to see whether nausea appears. The important facts are the exact product, intended dose, possible amount delivered, device, timing, symptoms, co-medications, and who took it. A toxicology professional can interpret those facts together.

Call emergency services now for trouble breathing, swelling of the face or throat, collapse, seizure, inability to wake, severe confusion, or another immediately life-threatening reaction. Do not drive yourself if you are impaired.

Dose-Error Triage Record

Gather what you can without delaying the call.

RecordWhy it matters
exact product name and strengthseparates Zepbound from another injectable and identifies the labeled amount per dose
device typea single-dose pen, single-dose vial, multi-dose vial, or KwikPen creates different uncertainty about how much was delivered
usual dose and scheduleshows the person's established exposure and whether a second administration was outside the plan
exact date and time of every possible dosedistinguishes a same-day duplicate from a dose taken on a different day
what happened during the injectionrecords a complete injection, uncertain delivery, leak, device problem, or intentional second attempt without guessing the amount absorbed
current symptoms and when they beganguides urgency and symptom-based treatment
insulin, sulfonylurea, and recent glucose readingsidentifies additional hypoglycemia risk
kidney disease, fluid restriction, pregnancy, and other major conditionschanges the consequence of vomiting, diarrhea, poor intake, and dehydration
all medicines and substances taken todayhelps the toxicologist assess combined effects and avoid unsafe compensation
package and device availablelets the caller read the exact label and lot information if asked

This record is useful precisely because it avoids a fake universal threshold. Two people with the same nominal extra dose can have different risks based on co-medications, symptoms, health conditions, and uncertainty about delivery.

What the FDA Label Says About Overdose

The label does not name a Zepbound antidote or publish a home-treatment protocol. Its operative standard is: "Appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms" [1]. This is the FDA-approved prescribing information speaking, not a HealthRX.com treatment instruction. The label also says observation and treatment may be needed, taking tirzepatide's approximately five-day half-life into account [1].

That long half-life does not mean symptoms will last exactly five days or that everyone must be observed for the same period. A half-life describes how exposure declines, not a discharge timer. Poison Control or the treating team determines the necessary setting and duration.

Do not induce vomiting. Do not take extra insulin, glucose-lowering medicine, anti-nausea medicine, laxatives, or large fluid amounts to "cancel" the dose unless a clinician or toxicologist who knows the case directs it. Do not use another person's glucose plan.

Figure 1

Zepbound exposure in hours: time to peak, minimum dose gap and half-life

Zepbound exposure in hours: time to peak, minimum dose gap and half-lifeTimeline in hours. Time to peak blood level after an injection: 8 to 72 hours, median 24 hours. The shortest gap the label allows between two doses: 72 hours (3 days). Elimination half-life: about 5 days (120 hours), stated as 5 to 6 days (up to 144 hours) in the pharmacology section. One weekly dosing interval: 7 days (168 hours).Time to peak blood level after an injection (label range)8 to 72 hShortest gap the label allows between two dosesat least 72 h (3 days)Elimination half-life (time for the level to fall by half)about 5 days (120 h)up to 6 daysOne weekly dosing interval7 days (168 h)0 h24 h72 h120 h168 hHours (each bar is a length of time stated in the label)Median time to peak blood level: 24 hours
Zepbound exposure in hours: time to peak, minimum dose gap and half-lifeTimeline in hours. Time to peak blood level after an injection: 8 to 72 hours, median 24 hours. The shortest gap the label allows between two doses: 72 hours (3 days). Elimination half-life: about 5 days (120 hours), stated as 5 to 6 days (up to 144 hours) in the pharmacology section. One weekly dosing interval: 7 days (168 hours).Time to peak blood level after an injection (labelrange)8 to 72 hShortest gap the label allows between two dosesat least 72 h (3 days)Elimination half-life (time for the level to fall byhalf)about 5 days (120 h)up to 6 daysOne weekly dosing interval7 days (168 h)0 h24 h72 h120 h168 hHours (each bar is a length of time stated in the label)Median time to peak blood level: 24 hours
Lengths of time stated in the label for a normal prescribed dose, drawn on one scale in hours. After an injection the blood level peaks at a median of 24 hours (range 8 to 72), and the elimination half-life, the time for the level to fall by half, is about 5 days: close to the whole week between doses. That is why the label says observation may be needed after an overdose. The bars do not show when symptoms start or stop, and they are not an observation period for any one person. Source: Zepbound prescribing information, section 12.3, section 2.3, section 10 [1].
Show the numbers behind this chart
Zepbound exposure in hours: time to peak, minimum dose gap and half-life
Label figureFrom (hours)To (hours)What applies
Time to peak blood level after an injection (label range)8728 to 72 h
Shortest gap the label allows between two doses072at least 72 h (3 days)
Elimination half-life (time for the level to fall by half)0120about 5 days (120 h)
Elimination half-life (time for the level to fall by half)120144up to 6 days
One weekly dosing interval01687 days (168 h)
Marker24Median time to peak blood level: 24 hours

Symptoms the Team Will Ask About

Gastrointestinal symptoms and dehydration

Nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia are among Zepbound's common labeled adverse reactions [1]. With an extra dose, the treating team will care about severity, repeated vomiting, ability to keep fluids down, urine output, dizziness, and worsening abdominal pain.

The label warns about acute kidney injury related to adverse reactions that can cause volume depletion. Someone with kidney disease, a diuretic, or a fluid restriction should not follow a generic instruction to drink a fixed volume.

Low glucose risk with other medicines

Zepbound can increase hypoglycemia risk when used with insulin or an insulin secretagogue such as a sulfonylurea [1]. Sweating, shakiness, confusion, unusual behavior, weakness, seizure, or loss of consciousness can be warning signs. Follow the person's established emergency glucose plan while seeking immediate professional guidance; do not invent a new insulin adjustment.

Severe abdominal pain or hypersensitivity

Persistent severe abdominal pain, especially with vomiting, requires prompt evaluation because pancreatitis and gallbladder disease are labeled risks. Trouble breathing, facial or throat swelling, widespread hives, collapse, or rapidly worsening allergic symptoms are emergencies.

What Published Exposure Data Can and Cannot Answer

A 2025 retrospective cohort described 152 GLP-1 or dual GLP-1/GIP agonist exposures managed in emergency departments across three poison centers [3]. It can help toxicologists recognize patterns, but it combined products, excluded some important exposure types, and does not establish a home-management threshold for a specific Zepbound dose. National poison-center surveillance likewise shows that therapeutic errors are common, but surveillance counts cannot predict one person's outcome [4].

That is why this page does not turn a milligram total into a green, amber, or red score. The current label and poison-center pathway remain more applicable to the immediate decision.

Double Dose, Early Dose, Partial Dose, and Missed Dose Are Different

A confirmed second full dose is not the same as taking the weekly dose one day early. An uncertain injection is not proof that no medicine was delivered. A missed dose is different again.

The routine missed-dose rule says that a missed Zepbound dose may be taken within four days, or 96 hours. After more than four days, it should be skipped and the regular schedule resumed. The label also requires at least three days, or 72 hours, between doses [1]. Those rules help manage an ordinary missed dose. They are not permission to self-manage a suspected double dose.

If a device leaked, stopped, or appeared to deliver only part of a dose, do not automatically inject again. Record what happened and contact the pharmacist, prescriber, manufacturer device-support channel, or Poison Control based on the possibility of excess exposure and any symptoms.

For future missed-dose decisions, use the Zepbound missed-dose guide. If a longer interruption has already occurred, the Zepbound restart guide explains why the label's single missed-dose rule does not establish a universal restart dose.

Figure 2

Extra, early, partial or missed: sorting a Zepbound dose error

Decision diagram. First: trouble breathing or swallowing, swelling of the face or throat, fainting, a seizure or severe confusion means calling emergency services now. Otherwise, if more medicine than prescribed may have gone in, from a second dose or a larger amount, call Poison Help at 1-800-222-1222 or use webPOISONCONTROL now, even with no symptoms. A dose taken less than 72 hours (3 days) after the previous one means calling Poison Help or the prescriber. A leaking pen or partial dose means not injecting again and asking the pharmacist, prescriber or device support. A missed dose is not an overdose and follows the label's missed-dose rule. The label names no antidote: treatment is supportive, and observation may be needed because the half-life is about 5 days.
A way to sort the first call, not a risk score. Any chance of extra exposure goes to Poison Help or a medical toxicologist whatever the amount, because the label sets no home-management threshold. A leak or partial dose is not a reason to inject again, and a missed dose is not an overdose at all. Sources: Zepbound prescribing information, section 10, Medication Guide [1]; Poison Control (National Capital Poison Center), Tirzepatide overdose [2].
Text version of this diagram
  1. Is anyone having trouble breathing or swallowing, swelling of the face or throat, fainting, a seizure or severe confusion?
    • Yes: Call emergency services now. Take the pen or vial along if it is safe to do so.
    • No: Keep the device and its box, then work out what happened.
  2. Could more medicine than prescribed have gone in, from a second dose or a larger amount?
    • Yes, or not sure: Call Poison Help at 1-800-222-1222 or use webPOISONCONTROL now, even with no symptoms. Do not try to cancel the dose with other medicines.
    • No: Check the timing and the device next.
  3. Which of these describes it?
    • Doses under 72 h apart: The label requires at least 72 hours (3 days) between doses. Call Poison Help or the prescriber rather than judging the risk yourself.
    • Leak or partial dose: Do not inject again. Write down what you saw and ask the pharmacist, prescriber or device support before the next dose.
    • Missed dose: Not an overdose. Use the label's missed-dose rule for the next injection.
  4. What the label says about overdose: No antidote is named. Treatment is supportive, guided by signs and symptoms, and observation may be needed because tirzepatide's half-life is about 5 days.

What Happens After the First Call

Poison Control or the treating team may ask you to monitor at home, obtain glucose readings, seek urgent evaluation, or call emergency services. The answer depends on the record above, not a website severity score.

If evaluation is recommended, bring the medication and device if it is safe to do so. Do not discard the pen or vial until the situation is resolved. Write down the advice, the time of the call, the next scheduled dose, and who will decide whether that dose is held or changed.

An adverse event or device problem can also be reported to FDA MedWatch after immediate safety needs are addressed. Reporting does not replace Poison Control or emergency care.

Preventing a Repeat Without Blame

Dose errors often come from a changed injection day, two people sharing responsibility, a confusing device, a partial-dose concern, or a schedule that was not recorded. A simple prevention record can include:

  • one named person responsible for confirming the weekly dose;
  • a single calendar entry made immediately after injection;
  • the exact strength and device stored with the schedule;
  • a rule not to repeat an uncertain injection before speaking with a pharmacist or prescriber; and
  • a written missed-dose instruction from the current label.

Do not share a Zepbound pen between people. The current label also includes device-specific instructions that should be read for the exact presentation dispensed [1].

After a Dose Error

Contact Poison Help or a medical toxicologist immediately, gather the product and dose-error record, and follow the treating team's instructions. Supportive care and observation depend on the symptoms and actual exposure.

Frequently asked questions

What should I do if I took two doses of Zepbound?
Call Poison Help at 1-800-222-1222 or use webPOISONCONTROL now. Do not wait for symptoms, induce vomiting, or change other medicines to compensate unless a toxicology or treating professional directs you.
Is there an antidote for tirzepatide overdose?
The current FDA label does not identify a specific antidote. It calls for Poison Help or medical-toxicology guidance and supportive treatment based on signs and symptoms.
How long can an extra Zepbound dose affect me?
Tirzepatide's half-life is about five days. The label says observation and treatment may be necessary with that long half-life in mind, but it does not give one symptom duration or observation period for everyone.
Should I inject again if the pen leaked?
Do not automatically repeat an uncertain dose. Record the device, strength, what you saw, and when it happened, then contact the pharmacist, prescriber, manufacturer support, or Poison Control based on the possibility of excess exposure and any symptoms.
What if I took Zepbound one day early?
The label requires at least 72 hours between doses. If the timing was closer, the amount is uncertain, or you have symptoms, contact Poison Help or the prescribing team rather than trying to calculate the risk yourself.
Can a double dose cause low blood sugar?
Risk is higher when Zepbound is combined with insulin or a sulfonylurea. Tell Poison Control about those medicines and follow the person's established emergency glucose plan while seeking immediate help for severe symptoms.

References

  1. Eli Lilly and Company. Zepbound (tirzepatide) current U.S. prescribing information, revised August 2026. See section 10, "Overdosage." https://pi.lilly.com/us/zepbound-uspi.pdf

  2. National Capital Poison Center. Tirzepatide (Zepbound) for weight loss. https://www.poison.org/articles/tirzepatide-for-weight-loss

  3. Gartner HT, Simmons RE, Wan HZ, Sollee DR, Sheikh S. Clinical outcomes of glucagon-like peptide-1 receptor agonist (GLP-1 RA) and glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist (GLP-1/GIP RA) exposures presenting to the emergency department. Annals of Pharmacotherapy. 2025;59(12):1057-1068. doi:10.1177/10600280251334642. PMID:40269635. DOI record

  4. America's Poison Centers. GLP-1 exposure surveillance and prevention. Accessed August 29, 2026. https://www.poisoncenters.org/track/GLP-1

Two unbranded injection pens beside a dose calendar, Poison Help phone, and symptom record
A suspected extra dose calls for immediate poison-center guidance and an exact dose-error record, not a home antidote or compensation calculation. Image: HealthRX.com custom clinical image